Clinical Trial

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of the study is to: * Establish and evaluate a system for collection of filgrastim-mobilized peripheral blood stem cells from National Marrow Donor Program donors (NMDP) donors * Assess the safety among NMDP donors of filgrastim administration and PBSC leukapheresis * Assess the safety and efficacy of filgrastim-mobilized PBSC in unrelated donor hematopoietic stem cell transplant recipients * Determine the acceptability of stem cell donation by filgrastim stimulated apheresis in normal donors
Protocol Amendment History 30 amendments
This ClinicalTrials.gov record has been amended 30 times since 2008-11-04; most recent amendment 2025-04-09.
Trial Details
NCT Number NCT00785525
Lead Sponsor Center for International Blood and Marrow Transplant Research
Collaborators: National Marrow Donor Program
Conditions Healthy
Enrollment 60,000 participants
Start Date 1997-02
Primary Completion 2030-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-13